September 25, 2024 —
NIH-funded analysis suggests higher doses of buprenorphine were associated with lower rates of future behavioral health-related emergency department and inpatient care.
September 24, 2024 —
NIH findings highlight critical gaps in treatment access in correctional facilities, where almost two-thirds of people have a substance use disorder.
